[1] K. D. Corbin et al., "Host-diet-gut microbiome interactions influence human energy balance: a randomized clinical trial," Nature Communications, vol. 14, art. 3161, 2023, doi: 10.1038/s41467-023-38778-x.
[2] P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiome with increased capacity for energy harvest," Nature, vol. 444, no. 7122, pp. 1027–1031, 2006, doi: 10.1038/nature05414.
[3] Y. Zeng, Y. Wu, Q. Zhang, and X. Xiao, "Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases," mBio, vol. 15, no. 1, art. e0203223, 2024, doi: 10.1128/mbio.02032-23.
[4] Z. Li, J. Yao, S. Wang, J. Xu, and X. Wu, "Therapeutic potential of modulating endogenous PYY expression for controlling overweight and obesity: a narrative review," Frontiers in Nutrition, vol. 13, art. 1799041, 2026, doi: 10.3389/fnut.2026.1799041.
[5] P. D. Cani et al., "Metabolic endotoxemia initiates obesity and insulin resistance," Diabetes, vol. 56, no. 7, pp. 1761–1772, 2007, doi: 10.2337/db06-1491.
[6] L. Chen et al., "Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation," Frontiers in Endocrinology, 2026, doi: 10.3389/fendo.2026.1856667.
[7] E. Le Chatelier et al., "Richness of human gut microbiome correlates with metabolic markers," Nature, vol. 500, no. 7464, pp. 541–546, 2013, doi: 10.1038/nature12506.
[8] V. Mansuy-Aubert and Y. Ravussin, "Short chain fatty acids: the messengers from down below," Frontiers in Neuroscience, vol. 17, art. 1197759, 2023, doi: 10.3389/fnins.2023.1197759.
[9] Y. Wang et al., "Short-chain fatty acids: bridges between diet, gut microbiota, and health," Journal of Gastroenterology and Hepatology, 2024, doi: 10.1111/jgh.16619.
[10] F. Magne et al., "The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?" Nutrients, vol. 12, no. 5, art. 1474, 2020, doi: 10.3390/nu12051474.
[11] Z. Chen and L. Gautron, "Gut-derived lipopolysaccharides and metabolic endotoxemia: a critical review," American Journal of Physiology-Endocrinology and Metabolism, 2025, doi: 10.1152/ajpendo.00355.2025.
[12] C. Depommier et al., "Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study," Nature Medicine, vol. 25, no. 7, pp. 1096–1103, 2019, doi: 10.1038/s41591-019-0495-2.
[13] M. Niu et al., "Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases," Frontiers in Immunology, vol. 15, art. 1370658, 2024, doi: 10.3389/fimmu.2024.1370658.
[14] K. Wijarnpreecha et al., "Obesity and risk of small intestine bacterial overgrowth: a systematic review and meta-analysis," Digestive Diseases and Sciences, vol. 65, no. 5, pp. 1414–1422, 2020, doi: 10.1007/s10620-019-05887-x.
[15] M. Camilleri, "Is intestinal permeability increased in obesity? A review including the effects of dietary, pharmacological and surgical interventions on permeability and the microbiome," Diabetes, Obesity and Metabolism, 2023, PMCID: PMC10112051.
[16] A. Borrego-Ruiz and J. J. Borrego, "The gut microbiome in human obesity: a comprehensive review," Biomedicines, vol. 13, no. 9, art. 2173, 2025, doi: 10.3390/biomedicines13092173.
[17] M. Vinelli et al., "Effects of dietary fibers on short-chain fatty acids and gut microbiota composition in healthy adults: a systematic review," Nutrients, vol. 14, no. 13, art. 2559, 2022, doi: 10.3390/nu14132559.
[18] H. C. Wastyk et al., "Gut-microbiota-targeted diets modulate human immune status," Cell, vol. 184, no. 16, pp. 4137–4153, 2021, doi: 10.1016/j.cell.2021.06.019.
[19] D. McDonald et al., "American Gut: an open platform for citizen science microbiome research," mSystems, vol. 3, no. 3, art. e00031-18, 2018, doi: 10.1128/mSystems.00031-18.
[20] K. D. Hall et al., "Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake," Cell Metabolism, vol. 30, no. 1, pp. 67–77.e3, 2019, doi: 10.1016/j.cmet.2019.05.008.
[21] R. von Schwartzenberg et al., "Caloric restriction disrupts the microbiota and colonization resistance," Nature, vol. 595, pp. 272–277, 2021, doi: 10.1038/s41586-021-03663-4.
[22] J. Lin et al., "Associations of short sleep duration with appetite-regulating hormones and adipokines: a systematic review and meta-analysis," Obesity Reviews, vol. 21, no. 11, art. e13051, 2020, doi: 10.1111/obr.13051.
[23] K. Spiegel, E. Tasali, P. Penev, and E. Van Cauter, "Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite," Annals of Internal Medicine, vol. 141, no. 11, pp. 846–850, 2004, doi: 10.7326/0003-4819-141-11-200412070-00008.
[24] E. L. Lengton et al., "Glucocorticoids and HPA axis regulation in the stress–obesity connection: a comprehensive overview of biological, physiological and behavioural dimensions," Clinical Obesity, 2025, doi: 10.1111/cob.12725.
[25] E. S. van der Valk, M. Savas, and E. F. C. van Rossum, "Stress and obesity: are there more susceptible individuals?" Current Obesity Reports, vol. 7, pp. 193–203, 2018, doi: 10.1007/s13679-018-0306-y.
[26] S. Kalra, S. Aggarwal, and D. Khandelwal, “Thyroid Dysfunction and Dysmetabolic Syndrome: The Need for Enhanced Thyrovigilance Strategies,” Int J Endocrinol, vol. 2021, p. 9641846, 2021, doi: 10.1155/2021/9641846.
[27] S. Saadati et al., "Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: a systematic review and meta-analysis," Obesity Reviews, 2024, doi: 10.1111/obr.13667.
[28] M. U-Din et al., “Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults,” J Clin Endocrinol Metab, vol. 109, no. 3, pp. 680–690, Feb. 2024, doi: 10.1210/clinem/dgad604.